Academic Journal

Efficacy of lanreotide 120 mg primary therapy on tumor shrinkage and ophthalmologic symptoms in acromegaly after one month.

التفاصيل البيبلوغرافية
العنوان: Efficacy of lanreotide 120 mg primary therapy on tumor shrinkage and ophthalmologic symptoms in acromegaly after one month.
المؤلفون: Benderradji, H., Vernotte, E., Ares, G. S., Woillez, J. P., Arnaud, J., Perbet, R., Karnoub, M. A., Soudan, B., Assaker, R., Buee, Luc, Prevot, Vincent, Maurage, C. A., Pigny, P., Vantyghem, M. C., Merlen, E., Cortet, C.
المساهمون: Université de Lille, Inserm, CHU Lille, Lille Neurosciences & Cognition (LilNCog) - U 1172
سنة النشر: 2022
المجموعة: LillOA (Lille Open Archive - Université de Lille)
مصطلحات موضوعية: visual field defects, treatment response, optic chiasm compression, MRI, lanreotide, first-generation somatostatin analogues, acromegaly
نوع الوثيقة: article in journal/newspaper
اللغة: unknown
Relation: Clin Endocrinol (Oxf); http://hdl.handle.net/20.500.12210/77147
الاتاحة: https://hdl.handle.net/20.500.12210/77147
Rights: info:eu-repo/semantics/closedAccess
رقم الانضمام: edsbas.63D98DF9
قاعدة البيانات: BASE